Join StocksJar.com -Get 7 Days Free trial

IQVIA (IQV) Stock Price & AI Analysis

NYSE
USA

$203.17

-$0.47
(-0.38%)

Subscribe to get
AI Score

  • Market Cap 36.88B
  • Volume 1.03M
  • Avg Volume 1.50M
  • Target Price $271.24
  • 52W Range 187.62 - 261.73
  • RSI (14) 44.51
  • Beta 1.49
  • PEG Ratio 2.58
  • SMA 20 -0.5300
  • SMA 50 -6.44
  • SMA 200 -11.92
  • Insider Owner 0.82%
  • Insider Trans -0.09%
  • Institution Owner 92.82%
  • Institution Trans 2.71%
  • Short Interest 3.34%
  • EPS next Y 8.41

IQVIA Company Profile

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm’s life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm’s life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

IQVIA | Latest news

IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y

IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y

IQVIA Holdings Inc. IQV reported solid second-quarter 2023 results, wherein earnings and revenues...

Zacks - 1 year ago

Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now

Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now

IQVIA (IQV) is benefitting from its robust capabilities and expansive strategy amid low liquidity...

Zacks - 8 months ago

Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight

Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight

IQVIA Holdings Inc (NYSE:IQV) showcases robust revenue growth in the latest quarter, signaling...

GuruFocuscom - 1 month ago

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Let's talk about the popular IQVIA Holdings Inc. (NYSE:IQV). The company's shares saw a double-digit share price rise of over 10% in the past couple of...

Simply Wall St - 1 year ago

IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock...

IQVIA Holdings Inc. (IQV): Hedge Funds Are Bullish On This Trending AI Stock...

We recently compiled a list of the 10 Trending AI Health Stocks. In this article, we are going to...

Insider Monkey - 2 months ago

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 64% Above Its...

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 64% Above Its...

Key Insights IQVIA Holdings' estimated fair value is US$339 based on 2 Stage Free Cash Flow to...

Simply Wall St - 5 months ago

What Makes IQVIA Holdings (IQV) a Worthy Long-Term Investment?

What Makes IQVIA Holdings (IQV) a Worthy Long-Term Investment?

Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” second quarter 2023...

Insider Monkey - 1 year ago

IQVIA (IQV) to Report Q1 Earnings: What's in the Offing?

IQVIA (IQV) to Report Q1 Earnings: What's in the Offing?

IQVIA Holdings' (IQV) first-quarter 2024 revenues are likely to have benefited from growth in the...

Zacks - 7 months ago

IQVIA Holdings Inc. (NYSE:IQV): A Non-Tech Stock With Long-Term Investment...

IQVIA Holdings Inc. (NYSE:IQV): A Non-Tech Stock With Long-Term Investment...

We recently compiled a list of the 35 Non-Tech Stocks With Long-Term Investment Potential. In this...

Insider Monkey - 3 months ago

Will IQVIA Holdings (IQV) Bounce Back?

Will IQVIA Holdings (IQV) Bounce Back?

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” second quarter 2024 investor letter. A copy of the letter can...

Insider Monkey - 5 months ago